Algert Global LLC raised its holdings in SelectQuote, Inc. (NYSE:SLQT – Free Report) by 147.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 50,429 shares of the company’s stock after acquiring an additional 30,019 shares during the quarter. Algert Global LLC’s holdings in SelectQuote were worth $139,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Jacobs Levy Equity Management Inc. boosted its position in shares of SelectQuote by 229.3% during the first quarter. Jacobs Levy Equity Management Inc. now owns 1,161,593 shares of the company’s stock worth $2,323,000 after purchasing an additional 808,850 shares in the last quarter. Panagora Asset Management Inc. boosted its position in shares of SelectQuote by 85.5% during the second quarter. Panagora Asset Management Inc. now owns 410,009 shares of the company’s stock worth $1,132,000 after purchasing an additional 189,029 shares in the last quarter. Headlands Technologies LLC bought a new position in shares of SelectQuote during the first quarter worth $36,000. Bank of New York Mellon Corp boosted its position in shares of SelectQuote by 14.1% during the second quarter. Bank of New York Mellon Corp now owns 472,849 shares of the company’s stock worth $1,305,000 after purchasing an additional 58,481 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of SelectQuote by 18.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,414 shares of the company’s stock worth $83,000 after purchasing an additional 6,555 shares in the last quarter. 34.59% of the stock is owned by institutional investors.
SelectQuote Trading Up 5.4 %
Shares of NYSE:SLQT opened at $2.25 on Friday. SelectQuote, Inc. has a 12 month low of $1.03 and a 12 month high of $4.46. The company has a quick ratio of 6.84, a current ratio of 6.84 and a debt-to-equity ratio of 2.01. The company’s fifty day simple moving average is $2.91 and its 200 day simple moving average is $2.79. The firm has a market cap of $384.93 million, a price-to-earnings ratio of -10.69 and a beta of 1.05.
Analyst Ratings Changes
Separately, Craig Hallum assumed coverage on shares of SelectQuote in a research report on Monday, September 30th. They set a “buy” rating and a $4.50 price target on the stock.
View Our Latest Research Report on SLQT
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Read More
- Five stocks we like better than SelectQuote
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- How to Read Stock Charts for Beginners
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Learn Technical Analysis Skills to Master the Stock Market
- 4 Quirky ETFs With Big Potential for Impressive Gains
Want to see what other hedge funds are holding SLQT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SelectQuote, Inc. (NYSE:SLQT – Free Report).
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.